Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy

Mod Pathol. 2005 May;18(5):651-5. doi: 10.1038/modpathol.3800333.

Abstract

This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of pulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of etanercept therapy. Biopsy findings showed an interstitial and air space lymphohistiocytic infiltrate with non-necrotizing granulomas, in the setting of negative cultures and special stains for microorganisms. The association with etanercept therapy and granulomatous reactions is discussed along with the differential diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Antigens, CD / analysis
  • Antigens, Differentiation, Myelomonocytic / analysis
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • CD3 Complex / analysis
  • CD5 Antigens / analysis
  • Cough / chemically induced
  • Cyclin D1 / analysis
  • Diagnosis, Differential
  • Dyspnea / chemically induced
  • Etanercept
  • Female
  • Granuloma / chemically induced
  • Granuloma / pathology
  • Histiocytes / chemistry
  • Histiocytes / drug effects
  • Histiocytes / pathology*
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Immunohistochemistry
  • Leukosialin
  • Lung Diseases / chemically induced
  • Lung Diseases / pathology*
  • Lymphocytes / chemistry
  • Lymphocytes / drug effects
  • Lymphocytes / pathology*
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Sialoglycoproteins / analysis

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Antirheumatic Agents
  • CD3 Complex
  • CD5 Antigens
  • CD68 antigen, human
  • Immunoglobulin G
  • Leukosialin
  • Receptors, Tumor Necrosis Factor
  • SPN protein, human
  • Sialoglycoproteins
  • Cyclin D1
  • Etanercept